SH

Sandeep Haldar

Active Director Director DIN 09025695
DIN 09025695 First appointment Jan 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Sandeep Haldar

Data last updated:

Sandeep Haldar is a Director at Elet Pharma Private Limited (since 2021). The company operates in Chemicals. Elet Pharma Private Limited reported revenue of ₹30.8 Lakh (FY 2025).

DIN 09025695
Primary Designation Director
Industry Chemicals
First Appointment 11 Jan 2021
Oldest Company Age 5 yrs
Largest company Elet Pharma Private Limited · ₹30.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elet Pharma Private Limited U24290PN2021PTC197605
Director11 Jan 20212021₹30.8 Lakh (FY 2025)Active

Board colleagues of Sandeep Haldar

Directorship timeline

Open interactive timeline →
Elet Pharma Private Limited
Premium access

Shareholding and investment profile for Sandeep Haldar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandeep Haldar

Sandeep Haldar currently holds 1 directorship: Elet Pharma Private Limited (Director, since 11 Jan 2021, revenue ₹30.8 Lakh (FY 2025)).

Sandeep Haldar was first appointed on 11 Jan 2021 as Director at Elet Pharma Private Limited.

The current boards of Sandeep Haldar's companies include Sanjeev Kumar Haldar (Elet Pharma Private Limited), Vishal Chandra (Elet Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available